Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingfeng Liu

Showing results (321-330 of 330) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 330 results.
Eclinicalmedicine|July 29, 2024
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort studyLiangxu Guo, Xin Hao, Lei Chen, et al.
Science China. Life Sciences|March 22, 2022
Expert consensus on organizing the multidisciplinary team (MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in ChinaBinhao Zhang, Jian Zhou, Weifen Xie, et al.
Science China. Life Sciences|February 9, 2018
42,573 cases of hepatectomy in China: a multicenter retrospective investigationBinhao Zhang, Bixiang Zhang, Zhiwei Zhang, et al.
Cell Research|November 25, 2025
Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal agesHui-Hui Hu, Xuefeng Wang, Bin Lan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II TrialJianming Xu, Jie Shen, Shanzhi Gu, et al.
Journal of Hepatology|June 11, 2023
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signaturesRong Fan, Lei Chen, Siru Zhao, et al.
Journal of Hepatology|May 21, 2021
The Chinese Society of Hepatology position statement on the redefinition of fatty liver diseaseYuemin Nan, Jihong An, Jianfeng Bao, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.
Hepatobiliary Surgery and Nutrition|December 13, 2024
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition)Xi Xu, Tao Lv, Gang Xu, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Pageof 33

Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
Eclinicalmedicine|July 29, 2024
Early warning of hepatocellular carcinoma in cirrhotic patients by three-phase CT-based deep learning radiomics model: a retrospective, multicentre, cohort studyLiangxu Guo, Xin Hao, Lei Chen, et al.
Science China. Life Sciences|March 22, 2022
Expert consensus on organizing the multidisciplinary team (MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in ChinaBinhao Zhang, Jian Zhou, Weifen Xie, et al.
Science China. Life Sciences|February 9, 2018
42,573 cases of hepatectomy in China: a multicenter retrospective investigationBinhao Zhang, Bixiang Zhang, Zhiwei Zhang, et al.
Cell Research|November 25, 2025
Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal agesHui-Hui Hu, Xuefeng Wang, Bin Lan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II TrialJianming Xu, Jie Shen, Shanzhi Gu, et al.
Journal of Hepatology|June 11, 2023
Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signaturesRong Fan, Lei Chen, Siru Zhao, et al.
Journal of Hepatology|May 21, 2021
The Chinese Society of Hepatology position statement on the redefinition of fatty liver diseaseYuemin Nan, Jihong An, Jianfeng Bao, et al.
Hepatobiliary Surgery and Nutrition|April 25, 2022
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.
Hepatobiliary Surgery and Nutrition|December 13, 2024
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition)Xi Xu, Tao Lv, Gang Xu, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)Zheng Wang, Huichuan Sun, Jian Zhou, et al.
Pageof 33